This combination enhanced the in vivo anti-tumor effect and increased splenic CD4+Ki-67+ helper and CD8+Ki-67+ cytotoxic T lymphocytes, and tumor-infiltrating CD3+CD4+ helper and CD3+CD8+ cytotoxic T lymphocytes. The gene discussed is MKI67; the disease is neoplasm.